QID 240022

Date Published: 2022-01-25

QID 240022: Red Hat Update for libreswan (RHSA-2022:0239)

libreswan is an implementation of ipsec and ike for linux.
Ipsec is the internet protocol security and uses strong cryptography to provide both authentication and encryption services.
These services allow you to build secure tunnels through untrusted networks such as virtual private network (vpn).

Security Fix(es):
  • libreswan: malicious ikev1 packet can cause libreswan to restart (cve-2022-23094)

Affected Products:

  • Red Hat enterprise linux for x86_64 - extended update support 8.4 x86_64
  • Red Hat enterprise linux server - aus 8.4 x86_64
  • Red Hat enterprise linux for ibm z systems - extended update support 8.4 s390x
  • Red Hat enterprise linux for power, little endian - extended update support 8.4 ppc64le
  • Red Hat enterprise linux server - tus 8.4 x86_64
  • Red Hat enterprise linux for arm 64 - extended update support 8.4 aarch64
  • Red Hat enterprise linux server (for ibm power le) - update services for sap solutions 8.4 ppc64le
  • Red Hat enterprise linux server - update services for sap solutions 8.4 x86_64



Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as High - 7.5 severity.
  • CVSS V2 rated as Medium - 5 severity.
    • Solution
    Refer to Red Hat security advisory RHSA-2022:0239 for updates and patch information.
    Vendor References

    CVEs related to QID 240022

    CVE-2022-23094 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2022:0239 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2022:0239
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].